US and China Clarithromycin Prices Surge 2.5% in Sept 2025, as the Demand Improves

Key Highlights

• The pharmaceutical sector is the primary driver of clarithromycin demand, fueled by increased prescriptions and public health initiatives.
• Retail sales of clarithromycin have surged, reflecting heightened consumer awareness and healthcare access.
• The antibiotic market has experienced significant growth, with clarithromycin leading due to its efficacy against a variety of bacterial infections.
• Increased consumer spending on healthcare products has led to stockpiling of clarithromycin, further straining supply chains.

The price of clarithromycin has risen from USD xxx,xxx per metric ton in July to USD xxx,xxx per metric ton in September in China. Similarly, in the US, prices increased from USD xxx,xxx per metric ton to USD xxx,xxx per metric ton over the same timeframe. That x.xx increase reflects robust demand patterns in key end-use markets, most notably pharmaceuticals. Sales to retailers have risen as patients increasingly turn to effective treatments against bacterial disease, while industrial use is robust on account...